Janux Therapeutics
A Vice President of Regulatory Affairs & Quality Assurance at Janux Therapeutics provides strategic leadership for regulatory and quality functions, ensuring compliance and facilitating the development and commercialization of biotech products. The role involves collaboration with various teams, interaction with global health authorities, and overseeing regulatory and quality strategies across the company's pipeline.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Janux Therapeutics is a biotechnology company developing precision‑engineered T cell immunotherapies. They design novel therapeutics that selectively modulate T cells to treat cancer and autoimmune diseases while minimizing systemic safety issues. Their approach focuses on targeted modulation of immune responses to improve efficacy and reduce toxicity. Janux aims to translate selective T‑cell control into safer, more effective immunotherapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Janux Therapeutics.
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
1 month ago
Vice President, Regulatory Affairs
Contraline
Vice President, Head of Regulatory Affairs
Zevra
Senior Vice President, Regulatory Affairs
Mineralys Therapeutics
Executive Director, Regulatory Affairs
Beeline Medicines
Vice President, Regulatory Affairs
Prime Medicine
Vice President, Regulatory Affairs
Clinical Dynamix